Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 436 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 433 434 435 436 presentations: 1 to 25 of 10898
Therapeutic modulation of E3 ubiquitin ligase activity
Benjamin L. Ebert
Dana-Farber Cancer Institute, Boston, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 5:00 PM-7:00 PM
Navigating gene-gene and drug-gene interaction landscapes underpinning the DNA damage response
Daniel Durocher
Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 8:00 AM-9:45 AM
Background and use of circulating tumor-derived DNA and circulating tumor cells as biomarkers
Martijn Lolkema
Erasmus MC, Rotterdam, Netherlands
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 10:00 AM-11:45 AM
The KRASG12C inhibitor, MRTX849, provides insight toward therapeutic susceptibility of KRAS mutant cancers
James G Christensen
Mirati Therapeutics, San Diego, CA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
A phase 1 clinical trial evaluating the pharmacokinetics (PK), safety, and clinical activity of MRTX849, a mutant-selective small molecule KRASG12C inhibitor, in advanced solid tumors
Pasi A Jänne
Dana-Farber Cancer Institute, Boston, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
The dark side of immunotherapy
Emiliano Calvo
Start Madrid, Madrid, Spain
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 8:00 AM-9:45 AM
Inhibitors of the HSF1 stress pathway derived from phenotypic screening: Targeting non-oncogene addiction in ovarian and other cancers
Paul Workman
The Institute of Cancer Research, London, United Kingdom
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 10:00 AM-11:45 AM
Early lessons from initial acquired resistance to TRK inhibitors
David M Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 4:15 PM-6:00 PM
From big data to smart data: Overcoming biomedical reductionism
Sean Khozin
U.S. Food & Drug Administration, Silver Spring, MD, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 30, 2019 8:00 AM-9:45 AM
Identifying novel immunotherapy strategies using human samples and pre-clinical models
Jennifer L Guerriero
Dana-Farber Cancer Institute, Boston, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 30, 2019 10:00 AM-12:00 PM
Introduction of AACR President
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Elizabeth M. Jaffee
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Thirteenth Annual AACR Team Science Award Presentation
Recipients: St. Jude's Cancer Survivorship Research Team
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the 2019 AACR Distinguished Public Service Award
Recipient: Nancy F. Goodman
Founder, Kids v Cancer
Recognition of Michael Beveridge, Director of Electronic Communications, for 25 Years of Service to the AACR
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Acknowledgment of AACR Fellows Tasuku Honjo and James P. Allison for Receiving the 2018 Nobel Prize in Physiology or Medicine
Recognition of the Fellows of the AACR Academy
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Video: In Memoriam
Tribute to Waun Ki Hong
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the AACR June L. Biedler Prizes for Cancer Journalism
Recipients: Jacqueline Charles, Adam Piore, Caroline Chen, Riley Wong, Michele Gershberg, A.J. Lagoe, Jeff Kummer, Rob Stein
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the 2019 AACR Distinguished Public Service Award
Recipient: Louis M. Weiner, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the AACR Award for Lifetime Achievement in Cancer Research
Recipient: Emil J Freireich, University of Texas MD Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the 2019 AACR Distinguished Public Service Award
Recipient: Daniel D. Von Hoff, Translational Genomics Research Institute, Phoenix, AZ
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Presentation of the AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Recipient: Raymond N. DuBois, Medical University of South Carolina, Charleston, SC
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
AACR Initiatives: Summary of the Past Year
Elizabeth M. Jaffee, AACR President 2018-2019
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
NCI Directors' Remarks
Norman E. Sharpless
NCI Director
Douglas R. Lowy
NCI Deputy Director
from AACR Annual Meeting 2019 on March 31, 2019 8:00 AM-9:45 AM
Introduction
John D Carpten
USC Keck School of Medicine, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 9:45 AM-12:15 PM
Physicist vs. physician: Digitizing clinical assessment and using it for evidence-based prediction of outcomes
Peter Kuhn
USC, Los Angeles, CA, United States
Jorge J Nieva
USC Norris Comprehensive Cancer Ctr., Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 9:45 AM-12:15 PM
Therapeutic implications of DNA repair defects in cancer
Alan Ashworth
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 9:45 AM-12:15 PM
Precision oncology: Defining the actionable genome
David B Solit
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 31, 2019 9:45 AM-12:15 PM
<< first | < prev page: of 436 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 433 434 435 436 presentations: 1 to 25 of 10898